ArticleFrontiers in oncology2025
Global trends in esophageal cancer: sex and age disparities in health inequalities from 1990 to 2021, with projections to 2050.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A qualitative study exploring discharge readiness experiences among patients with esophageal cancer undergoing esophagectomy.International journal of qualitative studies on health and well-being · 2026Article
- Bisphenol A promotes esophageal carcinogenesis by activating the MMP1-PCOLCE regulatory axis and remodeling the tumor immune microenvironment.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Exploring the origins of esophagogastric junction cancer through omics: A focus on the Siewert II subclassification.Surgery today · 2026Review
- A prospective cohort study evaluating disease-specific mortality in patients with early-stage Barrett's esophagus-related neoplasia following endoscopic therapy.Surgical endoscopy · 2026Article
- Gender, racial, and stage-specific trends in esophageal cancer: Insights from longitudinal population data.World journal of gastrointestinal pathophysiology · 2025Article
- Global, regional, national burden, trends and health inequality of neglected tropical diseases and malaria from 1990 to 2021.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Esophageal cancer remains one of the deadliest cancers globally, highlighting significant health challenges and socioeconomic disparities. This study aims to measure its global burden, assess disparities by sex, age, and region, and evaluate health inequalities, with projections to 2050. The goal is to provide evidence to guide resource allocation and reduce the disease burden. Methods: Using data from the Global Burden of Disease (GBD) 2021 study, we analyzed trends in prevalence, incidence, mortality, and Disability-Adjusted Life Years (DALYs) across sexes, age groups, and 204 countries and territories. Age-standardized rates (ASR) were calculated to account for population age structures. Trends over time were assessed using the estimated annual percentage change (EAPC). Health inequalities were evaluated using the Slope Index of Inequality (SII) and Concentration Index (CI). Future burdens were projected using Bayesian Age-Period-Cohort (BAPC) models. Results: From 1990 to 2021, esophageal cancer cases increased: prevalence from 551.62 to 1004.2 thousand, incidence from 354.73 to 576.53 thousand, mortality from 356.26 to 538.6 thousand, and DALYs from 9753.57 to 12999.26 thousand. However, age-standardized rates declined: prevalence from 13.34 to 11.47, incidence from 8.86 to 6.65, mortality from 9.02 to 6.25, and DALYs from 235.32 to 148.56 per 100,000 people. The burden rises sharply after age 40, with males and low-SDI regions experiencing higher burdens. Health inequalities widened, with the SII for prevalence increasing from 2.52 to 5.67, and for deaths from 1.45 to 2.94. West Africa, North Europe, and North America saw rising prevalence rates, while East Asia showed a declining trend. A decreasing trend is observed in most countries and regions worldwide, particularly in East Asia, with projections suggesting a continued decline in the future. Conclusion: Although projections indicate a decreasing trend, health inequalities have intensified. Regions such as West Africa, North Europe, and North America are experiencing rising prevalence. To address these disparities, targeted interventions, enhanced healthcare access, and preventive measures in high-burden areas are essential to reduce the global burden and advance health equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.